Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells

Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 2010-08, Vol.87 (9), p.294-301
Hauptverfasser: Yamazaki, Takashi, Ohmi, Asako, Kurumaya, Haruka, Kato, Kenji, Abe, Takanori, Yamamoto, Hiroyuki, Nakanishi, Noriko, Okuyama, Ryuichi, Umemura, Mariko, Kaise, Toshikazu, Watanabe, Ryuya, Okawa, Yoshiko, Takahashi, Shigeru, Takahashi, Yuji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 301
container_issue 9
container_start_page 294
container_title Life sciences (1973)
container_volume 87
creator Yamazaki, Takashi
Ohmi, Asako
Kurumaya, Haruka
Kato, Kenji
Abe, Takanori
Yamamoto, Hiroyuki
Nakanishi, Noriko
Okuyama, Ryuichi
Umemura, Mariko
Kaise, Toshikazu
Watanabe, Ryuya
Okawa, Yoshiko
Takahashi, Shigeru
Takahashi, Yuji
description Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein ( CHOP) gene expression. We used a transient transfection system to express ATF5 and analyzed the regulation of CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. We showed that ATF5 activates the CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. These results suggested that the CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced CHOP gene expression level via the AARE1 site in HepG2 cells.
doi_str_mv 10.1016/j.lfs.2010.07.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_817605073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320510002936</els_id><sourcerecordid>817605073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</originalsourceid><addsrcrecordid>eNqFkc1q3DAUhUVpaaZpH6Cbol1XnlxJluyhq2FIMoVASkjXQpavMxpsy5XkQN6hD13NT7tMN7qI-52DdA4hnxksGTB1tV_2XVxyyHeolgDqDVmwuloVoAR7SxYAvCwEB3lBPsS4BwApK_GeXHBQsszMgvx-wKe5N8n5kfqOph3S3TyYkW629z_oE45Ip-AHnzDQ5uW4jylgjDQfkx8j0hTMGG1w09GkMzb5QNePN5I-O3NUrNcP14xGl5C68ey_w8kkPxi6xemWU4t9Hz-Sd53pI346z0vy8-b6cbMt7u5vv2_Wd4UtJaSiarlSUmDd8FWprGKildKg4IyrrjG1BW45X0nBjaiYlGXJRVOLjrG6UzkscUm-nnzz137NGJMeXDy8wIzo56hrVimQUIn_klW5OoTK60yyE2mDjzFgp6fgBhNeNAN9aEvvdW5LH9rSUOncVtZ8ObvPzYDtP8XfejLw7QRgTuPZYdDROhwtti6gTbr17hX7P684o1Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>749005528</pqid></control><display><type>article</type><title>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Yamazaki, Takashi ; Ohmi, Asako ; Kurumaya, Haruka ; Kato, Kenji ; Abe, Takanori ; Yamamoto, Hiroyuki ; Nakanishi, Noriko ; Okuyama, Ryuichi ; Umemura, Mariko ; Kaise, Toshikazu ; Watanabe, Ryuya ; Okawa, Yoshiko ; Takahashi, Shigeru ; Takahashi, Yuji</creator><creatorcontrib>Yamazaki, Takashi ; Ohmi, Asako ; Kurumaya, Haruka ; Kato, Kenji ; Abe, Takanori ; Yamamoto, Hiroyuki ; Nakanishi, Noriko ; Okuyama, Ryuichi ; Umemura, Mariko ; Kaise, Toshikazu ; Watanabe, Ryuya ; Okawa, Yoshiko ; Takahashi, Shigeru ; Takahashi, Yuji</creatorcontrib><description>Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein ( CHOP) gene expression. We used a transient transfection system to express ATF5 and analyzed the regulation of CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. We showed that ATF5 activates the CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. These results suggested that the CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced CHOP gene expression level via the AARE1 site in HepG2 cells.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2010.07.006</identifier><identifier>PMID: 20654631</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Activating Transcription Factors - antagonists &amp; inhibitors ; Activating Transcription Factors - genetics ; Activating Transcription Factors - physiology ; Activator protein 1 ; Amino Acids - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Arsenite ; Arsenites - pharmacology ; ATF5 ; Binding Sites ; Blotting, Western ; Cell Survival - drug effects ; CHOP ; Cloning, Molecular ; DDIT3 ; Dose-Response Relationship, Drug ; GADD153 ; Gene Deletion ; Gene Expression Regulation, Neoplastic - drug effects ; HeLa Cells ; Hep G2 Cells ; Humans ; Luciferases - genetics ; Plasmids ; Point Mutation ; Promoter Regions, Genetic ; Response Elements - genetics ; RNA, Small Interfering - pharmacology ; Sodium Compounds - pharmacology ; Transcription Factor AP-1 - genetics ; Transcription Factor CHOP - genetics ; Transfection ; Up-Regulation</subject><ispartof>Life sciences (1973), 2010-08, Vol.87 (9), p.294-301</ispartof><rights>2010 Elsevier Inc.</rights><rights>Copyright (c) 2010 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</citedby><cites>FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lfs.2010.07.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20654631$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamazaki, Takashi</creatorcontrib><creatorcontrib>Ohmi, Asako</creatorcontrib><creatorcontrib>Kurumaya, Haruka</creatorcontrib><creatorcontrib>Kato, Kenji</creatorcontrib><creatorcontrib>Abe, Takanori</creatorcontrib><creatorcontrib>Yamamoto, Hiroyuki</creatorcontrib><creatorcontrib>Nakanishi, Noriko</creatorcontrib><creatorcontrib>Okuyama, Ryuichi</creatorcontrib><creatorcontrib>Umemura, Mariko</creatorcontrib><creatorcontrib>Kaise, Toshikazu</creatorcontrib><creatorcontrib>Watanabe, Ryuya</creatorcontrib><creatorcontrib>Okawa, Yoshiko</creatorcontrib><creatorcontrib>Takahashi, Shigeru</creatorcontrib><creatorcontrib>Takahashi, Yuji</creatorcontrib><title>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein ( CHOP) gene expression. We used a transient transfection system to express ATF5 and analyzed the regulation of CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. We showed that ATF5 activates the CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. These results suggested that the CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced CHOP gene expression level via the AARE1 site in HepG2 cells.</description><subject>Activating Transcription Factors - antagonists &amp; inhibitors</subject><subject>Activating Transcription Factors - genetics</subject><subject>Activating Transcription Factors - physiology</subject><subject>Activator protein 1</subject><subject>Amino Acids - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Arsenite</subject><subject>Arsenites - pharmacology</subject><subject>ATF5</subject><subject>Binding Sites</subject><subject>Blotting, Western</subject><subject>Cell Survival - drug effects</subject><subject>CHOP</subject><subject>Cloning, Molecular</subject><subject>DDIT3</subject><subject>Dose-Response Relationship, Drug</subject><subject>GADD153</subject><subject>Gene Deletion</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>HeLa Cells</subject><subject>Hep G2 Cells</subject><subject>Humans</subject><subject>Luciferases - genetics</subject><subject>Plasmids</subject><subject>Point Mutation</subject><subject>Promoter Regions, Genetic</subject><subject>Response Elements - genetics</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>Sodium Compounds - pharmacology</subject><subject>Transcription Factor AP-1 - genetics</subject><subject>Transcription Factor CHOP - genetics</subject><subject>Transfection</subject><subject>Up-Regulation</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1q3DAUhUVpaaZpH6Cbol1XnlxJluyhq2FIMoVASkjXQpavMxpsy5XkQN6hD13NT7tMN7qI-52DdA4hnxksGTB1tV_2XVxyyHeolgDqDVmwuloVoAR7SxYAvCwEB3lBPsS4BwApK_GeXHBQsszMgvx-wKe5N8n5kfqOph3S3TyYkW629z_oE45Ip-AHnzDQ5uW4jylgjDQfkx8j0hTMGG1w09GkMzb5QNePN5I-O3NUrNcP14xGl5C68ey_w8kkPxi6xemWU4t9Hz-Sd53pI346z0vy8-b6cbMt7u5vv2_Wd4UtJaSiarlSUmDd8FWprGKildKg4IyrrjG1BW45X0nBjaiYlGXJRVOLjrG6UzkscUm-nnzz137NGJMeXDy8wIzo56hrVimQUIn_klW5OoTK60yyE2mDjzFgp6fgBhNeNAN9aEvvdW5LH9rSUOncVtZ8ObvPzYDtP8XfejLw7QRgTuPZYdDROhwtti6gTbr17hX7P684o1Y</recordid><startdate>20100828</startdate><enddate>20100828</enddate><creator>Yamazaki, Takashi</creator><creator>Ohmi, Asako</creator><creator>Kurumaya, Haruka</creator><creator>Kato, Kenji</creator><creator>Abe, Takanori</creator><creator>Yamamoto, Hiroyuki</creator><creator>Nakanishi, Noriko</creator><creator>Okuyama, Ryuichi</creator><creator>Umemura, Mariko</creator><creator>Kaise, Toshikazu</creator><creator>Watanabe, Ryuya</creator><creator>Okawa, Yoshiko</creator><creator>Takahashi, Shigeru</creator><creator>Takahashi, Yuji</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20100828</creationdate><title>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</title><author>Yamazaki, Takashi ; Ohmi, Asako ; Kurumaya, Haruka ; Kato, Kenji ; Abe, Takanori ; Yamamoto, Hiroyuki ; Nakanishi, Noriko ; Okuyama, Ryuichi ; Umemura, Mariko ; Kaise, Toshikazu ; Watanabe, Ryuya ; Okawa, Yoshiko ; Takahashi, Shigeru ; Takahashi, Yuji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Activating Transcription Factors - antagonists &amp; inhibitors</topic><topic>Activating Transcription Factors - genetics</topic><topic>Activating Transcription Factors - physiology</topic><topic>Activator protein 1</topic><topic>Amino Acids - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Arsenite</topic><topic>Arsenites - pharmacology</topic><topic>ATF5</topic><topic>Binding Sites</topic><topic>Blotting, Western</topic><topic>Cell Survival - drug effects</topic><topic>CHOP</topic><topic>Cloning, Molecular</topic><topic>DDIT3</topic><topic>Dose-Response Relationship, Drug</topic><topic>GADD153</topic><topic>Gene Deletion</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>HeLa Cells</topic><topic>Hep G2 Cells</topic><topic>Humans</topic><topic>Luciferases - genetics</topic><topic>Plasmids</topic><topic>Point Mutation</topic><topic>Promoter Regions, Genetic</topic><topic>Response Elements - genetics</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>Sodium Compounds - pharmacology</topic><topic>Transcription Factor AP-1 - genetics</topic><topic>Transcription Factor CHOP - genetics</topic><topic>Transfection</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamazaki, Takashi</creatorcontrib><creatorcontrib>Ohmi, Asako</creatorcontrib><creatorcontrib>Kurumaya, Haruka</creatorcontrib><creatorcontrib>Kato, Kenji</creatorcontrib><creatorcontrib>Abe, Takanori</creatorcontrib><creatorcontrib>Yamamoto, Hiroyuki</creatorcontrib><creatorcontrib>Nakanishi, Noriko</creatorcontrib><creatorcontrib>Okuyama, Ryuichi</creatorcontrib><creatorcontrib>Umemura, Mariko</creatorcontrib><creatorcontrib>Kaise, Toshikazu</creatorcontrib><creatorcontrib>Watanabe, Ryuya</creatorcontrib><creatorcontrib>Okawa, Yoshiko</creatorcontrib><creatorcontrib>Takahashi, Shigeru</creatorcontrib><creatorcontrib>Takahashi, Yuji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamazaki, Takashi</au><au>Ohmi, Asako</au><au>Kurumaya, Haruka</au><au>Kato, Kenji</au><au>Abe, Takanori</au><au>Yamamoto, Hiroyuki</au><au>Nakanishi, Noriko</au><au>Okuyama, Ryuichi</au><au>Umemura, Mariko</au><au>Kaise, Toshikazu</au><au>Watanabe, Ryuya</au><au>Okawa, Yoshiko</au><au>Takahashi, Shigeru</au><au>Takahashi, Yuji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2010-08-28</date><risdate>2010</risdate><volume>87</volume><issue>9</issue><spage>294</spage><epage>301</epage><pages>294-301</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein ( CHOP) gene expression. We used a transient transfection system to express ATF5 and analyzed the regulation of CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. We showed that ATF5 activates the CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells. These results suggested that the CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced CHOP gene expression level via the AARE1 site in HepG2 cells.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>20654631</pmid><doi>10.1016/j.lfs.2010.07.006</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2010-08, Vol.87 (9), p.294-301
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_817605073
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Activating Transcription Factors - antagonists & inhibitors
Activating Transcription Factors - genetics
Activating Transcription Factors - physiology
Activator protein 1
Amino Acids - pharmacology
Apoptosis
Apoptosis - drug effects
Arsenite
Arsenites - pharmacology
ATF5
Binding Sites
Blotting, Western
Cell Survival - drug effects
CHOP
Cloning, Molecular
DDIT3
Dose-Response Relationship, Drug
GADD153
Gene Deletion
Gene Expression Regulation, Neoplastic - drug effects
HeLa Cells
Hep G2 Cells
Humans
Luciferases - genetics
Plasmids
Point Mutation
Promoter Regions, Genetic
Response Elements - genetics
RNA, Small Interfering - pharmacology
Sodium Compounds - pharmacology
Transcription Factor AP-1 - genetics
Transcription Factor CHOP - genetics
Transfection
Up-Regulation
title Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T21%3A09%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20the%20human%20CHOP%20gene%20promoter%20by%20the%20stress%20response%20transcription%20factor%20ATF5%20via%20the%20AARE1%20site%20in%20human%20hepatoma%20HepG2%20cells&rft.jtitle=Life%20sciences%20(1973)&rft.au=Yamazaki,%20Takashi&rft.date=2010-08-28&rft.volume=87&rft.issue=9&rft.spage=294&rft.epage=301&rft.pages=294-301&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2010.07.006&rft_dat=%3Cproquest_cross%3E817605073%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=749005528&rft_id=info:pmid/20654631&rft_els_id=S0024320510002936&rfr_iscdi=true